Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,095,562
  • Shares Outstanding, K 670,035
  • Annual Sales, $ 1,435 M
  • Annual Income, $ 30,590 K
  • 60-Month Beta 1.84
  • Price/Sales 2.19
  • Price/Cash Flow 26.96
  • Price/Book 1.80
Trade OPK with:

Options Overview

Details
  • Implied Volatility 104.44%
  • Historical Volatility 58.19%
  • IV Percentile 15%
  • IV Rank 19.03%
  • IV High 309.15% on 03/09/20
  • IV Low 56.34% on 01/20/21
  • Put/Call Vol Ratio 0.25
  • Today's Volume 2,658
  • Volume Avg (30-Day) 11,496
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 193,290
  • Open Int (30-Day) 246,775

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.05
  • Number of Estimates 3
  • High Estimate 0.05
  • Low Estimate 0.04
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +155.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.32 +0.35%
on 03/03/21
5.88 -26.28%
on 02/10/21
-0.99 (-18.52%)
since 02/03/21
3-Month
3.88 +11.73%
on 12/29/20
6.27 -30.86%
on 01/27/21
-0.28 (-6.17%)
since 12/03/20
52-Week
1.12 +288.06%
on 04/03/20
6.47 -33.00%
on 07/21/20
+2.86 (+192.91%)
since 03/03/20

Most Recent Stories

More News
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for somatrogon,...

PFE : 34.39 (+2.63%)
OPK : 4.32 (-6.49%)
Medical And Diagnostic Laboratory Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Medical And Diagnostic Laboratory Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027722/?utm_source=GNW...

OPK : 4.32 (-6.49%)
SKHCF : 24.7240 (+0.15%)
Enormous Growth of Global Prostate Cancer Diagnostics Market | Including Top Players like Abbott, MDxHealth, Genomic Health, 3D Signatures, OPKO Health, INC., Siemens Healthcare GmbH, DiaSorin S.p.A, F. Hoffman La Roche Ltd

 

DXD.VN : 0.040 (unch)
GHDX : 63.44 (-0.69%)
OPK : 4.32 (-6.49%)
SIEGY : 79.9600 (+2.05%)
New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19...

OPK : 4.32 (-6.49%)
OPKO Health (OPK) Q4 Earnings and Revenues Beat Estimates

OPKO Health's (OPK) fourth-quarter results benefit from strength in diagnostics.

ANGO : 21.55 (+2.23%)
HOLX : 71.97 (-3.81%)
ABT : 119.18 (-2.73%)
OPK : 4.32 (-6.49%)
OPKO Health (OPK) Q4 Earnings and Revenues Surpass Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of 25.00% and 13.41%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OPK : 4.32 (-6.49%)
OPKO Health: 4Q Earnings Snapshot

MIAMI (AP) _ Opko Health Inc. (OPK) on Thursday reported fourth-quarter net income of $32.3 million, after reporting a loss in the same period a year earlier.

OPK : 4.32 (-6.49%)
OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2020.

OPK : 4.32 (-6.49%)
OPKO Health (OPK) to Report Q4 Earnings: What's in Store?

OPKO Health's (OPK) fourth-quarter results are likely to reflect solid performance from Services and Products segment and RAYALDEE.

XRAY : 60.15 (+1.48%)
COO : 381.11 (-1.76%)
OPK : 4.32 (-6.49%)
OPCH : 19.12 (-2.10%)
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021

OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2020, as well as discuss financial guidance, after the close of the U.S. financial...

OPK : 4.32 (-6.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies.

See More

Key Turning Points

3rd Resistance Point 4.98
2nd Resistance Point 4.91
1st Resistance Point 4.76
Last Price 4.32
1st Support Level 4.54
2nd Support Level 4.47
3rd Support Level 4.32

See More

52-Week High 6.47
Fibonacci 61.8% 4.43
Last Price 4.32
Fibonacci 50% 3.79
Fibonacci 38.2% 3.16
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar